/
ADVB
$8.58+$0.98 (+12.89%)live
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
β
of holders' portfolios
13F filers
0
institutions
Market cap
$12.6M
2M shares
52-week range
$3.61 β $24.23
24% from low
Sector
SERVICES-MEDICAL LABORATORIES
Exchange
NASDAQ
CS
Change$-64.42
Advanced Biomed Inc. Common Stock
Advanced Biomed Inc operates through its subsidiaries and is mainly engaged in the research and development of various original microfluidic biochip technologies and the provision of tumor precision diagnosis and treatment technology applications. Through the joint application of semiconductor technology and biotechnology, it has developed various technologies and testing equipment for early screening and detection, diagnosis and staging, and treatment of cancer. Its devices: A+Pre, AC-1000, A+CellScan, and A+SCDrop, and three corresponding microfluidic biochips, A+Pre Chip and AC-1000 CTC Enrichment Chip, and A+CellScan Chip, are designed to provide rapid and affordable assay products and services to cancer patients.
www.advanbiomed.com- Employees
- 31
- IPO / List date
- Mar 6, 2025
- HQ
- RENO, NV
Held by traders on TradeandTell
No one on the platform currently holds ADVB.
Super investors & insiders
Institutions holding (13F)
No tracked institution reports a position in ADVB as of their last filing.
Insider activity (SEC Form 4)
Stock splits
| Execution date | Ratio |
|---|---|
| 2026-02-20 | 1-for-20reverse |
Recent trades on TradeandTell
No one on the platform has traded ADVB yet.
